LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Glen Eagle Advisors, LLC's Holding History (CIK: 0002029317)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 500 Value ($000) $1 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 500 Value ($000) $1 Avg Close $2.59 Range $2.14 - $3.00
Q1 2021
Shares 500 Value ($000) $1 Avg Close $2.40 Range $1.55 - $3.13
Q4 2020
Shares 500 Value ($000) $1 Avg Close $1.40 Range $0.93 - $2.01
Q3 2020
Shares 500 Value ($000) $0 Avg Close $0.88 Range $0.73 - $1.14
Q2 2020
Shares 500 Value ($000) $0 Avg Close $0.88 Range $0.70 - $1.20
Q1 2020
Shares 1,113 Value ($000) $1 Avg Close $1.00 Range $0.58 - $1.67
Q4 2019
Shares 1,863 Value ($000) $2 Avg Close $0.83 Range $0.53 - $1.02
Q3 2019
Shares 1,863 Value ($000) $2 Avg Close $1.03 Range $0.82 - $1.26